Affymax, Inc. (AFFY)

[aquaspin]

$AFFY .0002 now. Couchman needs to bring his companies current in filings

[Acme Investments]

E-Trade has cut the faucet off!! Loaded up and waiting to see how this plays out!!

[Acme Investments]

No problem! Just passing the time. The hunt for anything running can be time consuming!

[aquaspin]

Sorry for the late reply. It’s been a crazy busy couple of weeks at TSMC.

It’s crazy how much $AFFY and it’s brother $MYRX have sold off. This is to be expected till the end of September when these can’t be bought easily till Couchman brings them current.

I have no doubt that he will utilize the NOL’s so I’m not worried at all.

[Acme Investments]

Added a few more!!!

[Acme Investments]

Ask creeping up!! Keep your eyes peeled!!

[Acme Investments]

Added a few today. Looks like we may be at the bottom.

[Acme Investments]

I'm still keeping my eyes on it. They say volume comes first. Over 20mil and we have something cooking. One thing I've noticed is this trades heavy for a stock with 75mil.

[aquaspin]

Someone bought around 300k of the 400k ask at .035 yesterday.

[aquaspin]

I like how someone keeps taking out the .04 ask when it shows up. Just happened again this morning.

[Acme Investments]

Hang in there! Still on my radar. I will not sell one share. 10X or bust for me!!

[aquaspin]

Glad to see someone took out the .04 ask and made it the new bid. OTC markets are backed up at least 6 weeks as of last week. It doesn’t cost much to make $AFFY current through OTC basic pink current.
I’m really sure he already knows but I emailed Couchman to let him know that filing through basic OTC is a fraction of the cost of regular SEC filings that have other requirements attached to them.

[aquaspin]

Yes, I would wait to add. I think most OTC stop sign stocks will drop the next month or so till financials are updated. I’m assuming early August might be a good time to load the boat.

[aquaspin]

OTC markets has a huge backlog of filings to approve. We may not find out till September. I have a feeling that till then, people might get nervous and sell. I own 100k of AFFY and own 1.6 million of MYRX. I can’t buy anymore MYRX but I can buy more AFFY. If it gets taken down more in coming weeks, I will add more

[Acme Investments]

Good to hear!! I knew it was just a waiting game. The market is bearish so I will still wait to add.

[aquaspin]

I’m highly confident that Couchman will bring both $AFFY and $MYRX current. He just did the annual renewal for both of them in their residing states. Also, I’ve been looking at filings for companies that recently went pink current and it only costed them around $35k to do two years worth of financials to be current. Not much money at all considering

[Acme Investments]

Ask creeping up?? Lots of companies working behind the scenes to get current. Hopefully our number gets called.

[Acme Investments]

Use to sit at .018. Could walk it down lower. If it gets to .03 I'll start adding. No plans to sell.

[aquaspin]

$AFFY .051 someone wants out. Big sale. Just picked up more at .051

[Acme Investments]

You may be comparing apples to oranges. Each company has it's own fingerprint. I do agree our company has value but what the market thinks remains to be seen.

[aquaspin]

$EGXP .03 to $2.00 so far on merger news. It has $1.6 million NOL’s. $AFFY has $480 million NOL’s! Can’t wait till it’s AFFY’s turn for news!

[Acme Investments]

From the looks of Affy they are going to walk it down some more. I'll sit on the sidelines for a while until then. When the Sept deadline comes I'll make a decision.

[aquaspin]

There is no doubt in my mind that stock will run hard going forward. I imagine .20 or higher which would give $FBCD a $500 million market cap. I just hope $AFFY updates their financials so we could have a $500 million market cap here too (which would equate to about $6.75 for $AFFY)

Hopefully you make huge money on it then move some more money over here for more gains.

[Acme Investments]

Everybody has speculation on what the impact will be for the NOL'S for FBCd. What you're saying is speculation. Affy may prove to be more beneficial but at this time it's all speculation.

[aquaspin]

I just mentioned $AFFY on that board. FBCD’s NOLs will be of little use due to ownership change. AFFY never actually had an ownership change so all $500 million can be used.

I can’t wait till something happens here. We will be well off!

[Acme Investments]

Check out FBCd. It's an example of what can happen here. They are happy about a 27mil carry forward. We have 500 mil here!!

[aquaspin]

I totally agree. We have plenty of time. So much potential here. Dollars per share IMO

[Acme Investments]

Still keeping an eye on it. No rush for any parties involved. Could have easily sold out for profit. I believe they are holding out for the best possible deal.

[aquaspin]

Still have a 500k bid but I know what you mean. $AFFY will eventually be multiple dollars IMO

[Acme Investments]

I don't really trust those numbers they put up. Could be a ploy. I won't be selling any of my shares at 6. Worth way more. The stock can be revived at any time so not worried about grey's.

[aquaspin]

$AFFY - someone has a huge 500,000 bid in at .06. Maybe something happens soon? That’s a lot of money for a stock that could go to greys if not reporting by September!

[Acme Investments]

Interesting info. Till then I'll keep adding.

[aquaspin]

$AFFY...I’ve been doing some digging. CEO Couchman has hired this guy to do his filings and whatnot. Looks like he deals with mergers and the like:

https://www.olshanlaw.com/attorneys-Adam-Finerman.html

Here is a recent MYRX filing that has this guys name along with the well known company he works for on it:

https://sec.report/Document/0000921895-20-002102/

He is spending decent money by using this firm. My guess is for possible merger or acquisition for both $AFFY and $MYRX

Here is a list of the firms clients:

https://www.olshanlaw.com/clients.html

[aquaspin]

I don’t know of any other company that has a massive $480 million NOL’s. It would be perfect for a company that is already profitable since under the Jobs act, I believe they can go back 5 years to offset those profits. I could be wrong though.

[Acme Investments]

I'll keep pecking like a chicken with it's feed until then. This would make an excellent merger acquisition for someone.

[aquaspin]

I agree 100%. I am hoping this is the year that it happens. Every time I think about the remaining shares getting DTC approved a couple months ago, the more I think we close to seeing this get utilized.

[Acme Investments]

Now is the time to take advantage of this asset. Been sitting on this one for 10 years so no need for me to get impatient.

[aquaspin]

$AFFY - CEO Couchman has to be close to finding someone to utilize its massive $480 million NOL’s. That’s a huge tax savings for any profitable company.

Our big day is coming soon IMO

[Acme Investments]

Remember these. I use to think it might be a slight chance they would reinstate the drug. Then I stuck around for the NOL'S.

[aquaspin]

From the old $AFFY 10-K regarding Omontys:

If Takeda decides to reintroduce OMONTYS, which is highly uncertain, we are eligible to receive royalties and (i) potential commercial milestone payments totaling up to $180.0 million which consists of the following: (a) $10.0 million is payable upon the first commercial sale after reintroduction of OMONTYS in the U.S.; (b) $10.0 million and another $10.0 million relates to U.S. sales-based milestones, and (c) $150.0 million relates to sales-based milestones in amounts as previously disclosed outside of the U.S. but now including Japan as a result of the Amendment and (ii) a potential development milestone payment of $5.0 million payable either upon regulatory approval in the E.U. or Japan. The royalties are tiered in the range of 13% to 17% with respect to net sales in the U.S. and in the range of 13% to 24% depending on the level of net sales by Takeda worldwide outside of the U.S.

[aquaspin]

“ February 2013, the FDA had received 19 reports of severe anaphylactic reactions occurring within 30 min of a patient’s first dose. Indeed, among 19,428 patients who received intravenous peginesatide in a postapproval study, there were seven deaths due to anaphylaxis. The cause of this was not clear, but the preparation used in preapproval clinical trials was a single-dose vial, whereas the product used in dialysis units in the United States was a multidose vial with preservatives. Regardless, the manufacturer voluntarily withdrew peginesatide from further clinical use, and this drug is no longer available.”

I think AFFY should bring back Peginesatide but in single dose vials. Then we would be north of $20 a share IMO. Seemed like the drug was fine in single dose vials

[Acme Investments]

Sounds good to me!!

[aquaspin]

Very good sign indeed. Would like to see a .10 break and stay above that till news/filings come out.

[aquaspin]

Just a matter of time till we get some type of news here. I can’t wait for it. We will all do well with our AFFY shares

[Acme Investments]

Bid/Ask tightening up. Good sign!

[Acme Investments]

I think it's September. Money talks though. If a company contacts them and makes some arrangements that will buy more time.

[aquaspin]

Is the due date around the end of September? I was reading where the SEC was recommending that companies start the filing process by June so that it would be approved and whatnot by the deadline.

We know that Couchman and his BOD has a lot of experience in this field so it should be a fairly easy task for them to complete on time if not early

[Acme Investments]

He's on the clock whether he likes it or not. We will get an answer. He can't prolong it any longer.

[aquaspin]

I’m here to wait as long as it takes. Definitely have a strong feeling it will be this year for some reason.

Also, some people frown when Couchman doesn’t respond to the emails that are sent to him. There are reasons for this. First, he won’t say anything that isn’t already in old filings. Also, having too many shareholders would trigger a mandatory filing updating event which would be costly.

It will be a lot cheaper to be able to go through the basic reporting method through OTC markets.

[Acme Investments]

That's the thing about the market. It's just passing time till the fun starts. I think they call it, hurry up and wait.